STOCK TITAN

Teleflex to Present at the 40th Annual J.P. Morgan Healthcare Conference

Teleflex is set to have its Chairman, President, and CEO, Liam Kelly, speak at the 40th Annual J.P.

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Teleflex is set to have its Chairman, President, and CEO, Liam Kelly, speak at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 4:30 p.m. ET. The event will be accessible via a live audio webcast on the Teleflex investor relations website, along with presentation slides. Known for its innovative medical technologies aimed at improving health outcomes, Teleflex operates in diverse fields including vascular access, interventional cardiology, and emergency medicine. Further details can be found on their website.

Loading...
Loading translation...
Argus Session date unavailable
-0.05% session move Open Argus
Details

News Market Reaction – TFX

The recorded move for TFX in the trading session of this news was -0.05%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WAYNE, Pa., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 4:30 p.m. (ET).

A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at teleflex.com.

About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, QuickClot®, LMA®, Pilling®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.

Contacts:
Teleflex
Lawrence Keusch
Vice President, Investor Relations and Strategy Development

John Hsu, CFA
Vice President, Investor Relations

investor.relations@teleflex.com
610-948-2836


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Teleflex's presentation at the J.P. Morgan Healthcare Conference?

Teleflex's presentation is scheduled for January 11, 2022, at 4:30 p.m. ET.

Where can I watch Teleflex's presentation at the conference?

You can watch Teleflex's presentation via a live audio webcast on their investor relations website.

Who will be speaking for Teleflex at the conference?

Liam Kelly, the Chairman, President, and CEO of Teleflex, will be speaking at the conference.

What are the key areas of Teleflex's expertise?

Teleflex specializes in medical technologies across fields such as vascular access, interventional cardiology, anesthesia, and emergency medicine.

What is the stock symbol for Teleflex?

The stock symbol for Teleflex is TFX.

Keep reading